RUSSO, VINCENZO
 Distribuzione geografica
Continente #
AS - Asia 1.659
EU - Europa 1.643
NA - Nord America 1.254
SA - Sud America 521
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.121
Nazione #
US - Stati Uniti d'America 1.176
RU - Federazione Russa 1.085
SG - Singapore 583
CN - Cina 474
BR - Brasile 435
HK - Hong Kong 194
VN - Vietnam 188
IT - Italia 127
SE - Svezia 95
FR - Francia 88
BD - Bangladesh 69
DE - Germania 65
GB - Regno Unito 51
AR - Argentina 33
CA - Canada 33
FI - Finlandia 31
MX - Messico 30
IN - India 26
PL - Polonia 23
ID - Indonesia 21
ZA - Sudafrica 21
JP - Giappone 20
EC - Ecuador 17
AT - Austria 14
ES - Italia 14
IQ - Iraq 13
NL - Olanda 11
PK - Pakistan 11
UA - Ucraina 9
CL - Cile 8
CO - Colombia 8
VE - Venezuela 7
PY - Paraguay 6
SA - Arabia Saudita 6
TR - Turchia 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
KR - Corea 5
LT - Lituania 5
IE - Irlanda 4
PH - Filippine 4
TW - Taiwan 4
DO - Repubblica Dominicana 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
SI - Slovenia 3
TN - Tunisia 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
CR - Costa Rica 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
JO - Giordania 2
KH - Cambogia 2
MD - Moldavia 2
OM - Oman 2
TH - Thailandia 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
LB - Libano 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.121
Città #
Singapore 282
Dallas 275
Moscow 218
Hong Kong 189
Ashburn 160
San Jose 142
Beijing 82
Lauterbourg 68
Hefei 64
New York 58
Ho Chi Minh City 56
Shanghai 52
Los Angeles 39
São Paulo 39
Hanoi 36
Lawrence 35
Princeton 35
Milan 32
Orem 26
Tokyo 19
Warsaw 19
Johannesburg 18
Denver 16
Munich 16
Helsinki 15
Rio de Janeiro 15
Santa Clara 15
Frankfurt am Main 14
Mexico City 14
Naples 14
Turku 14
Nuremberg 13
Belo Horizonte 12
Poplar 12
The Dalles 12
Toronto 12
Boardman 11
Chennai 11
Washington 11
Haiphong 10
Rome 10
Chicago 9
Montreal 9
Phoenix 9
Porto Alegre 9
Atlanta 8
Biên Hòa 8
Brooklyn 8
Curitiba 8
Guayaquil 8
Houston 8
Amsterdam 7
Boston 7
Brasília 7
Falkenstein 7
Guangzhou 7
Hải Dương 7
London 7
Vienna 7
Bexley 6
Da Nang 6
Dhaka 6
Joinville 6
Maceió 6
San Francisco 6
Stockholm 6
Thái Nguyên 6
Buffalo 5
Campinas 5
Lahore 5
Osasco 5
Paris 5
Baghdad 4
Buenos Aires 4
Charlotte 4
Council Bluffs 4
Dublin 4
Goiânia 4
Guarulhos 4
Hortolândia 4
Phủ Lý 4
Pittsburgh 4
Querétaro 4
Quito 4
Rho 4
Ribeirão Preto 4
Salvador 4
St Louis 4
Teixeira de Freitas 4
Ankara 3
Barnet 3
Blumenau 3
Borgomanero 3
Bragança Paulista 3
Cairo 3
Carney 3
Clifton 3
El Progreso 3
Ferrara 3
Fortaleza 3
Totale 2.505
Nome #
Skin Photodamage and Melanomagenesis: A Comprehensive Review 133
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy 132
24-hydroxycholesterol participates in pancreatic neuroendocrine tumor development 119
A pilot phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma 115
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 114
Cholesterol: a putative oncogenic driver for DLBCL 112
A dual role for genetically modified lymphocytes in cancer immunotherapy 112
Anorectal melanoma: Clinico-pathological features of a rare and aggressive malignancy in a multicentric study 108
LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling 104
ACQUISITION OF INTACT ALLOGENEIC HUMAN LEUKOCYTE ANTIGEN MOLECULES BY HUMAN DENDRITIC CELLS 103
Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes 101
Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16-18 October 2008 96
Cancer immunity and immunotherapy beyond COVID-19 96
Subcutaneous insulin infusion (CSII) in italy: The third national survey 95
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle? 94
A family of rapidly evolving genes from the sex reversal critical region in Xp21 93
Abrogation of prostaglandin E2/EP4 signaling impairs the development of rag1+ lymphoid precursors in the thymus of zebrafish embryos 93
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies 91
Detection and functional analysis of tumor-derived LXR ligands 81
Autologous versus allogeneic cell-based vaccines? 80
Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT) 80
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020 80
Oxysterols recruit tumor-supporting neutrophils within the tumor microenvironment: The many facets of tumor-derived oxysterols 79
Immunohistochemical Investigation of Cyclooxygenase-2 Expression in Rabbit Uterine Adenocarcinoma and the Potential Use of COX-2 Inhibitors in Cancer Therapy 75
Cholesterol metabolites and tumor microenvironment: the road towards clinical translation 75
Discovery of 22(S)-23-phenyl-24-norchol-5-en-3β,22-diol (PFM046) as the first-in-class, steroidal, non-sulfated Liver X Receptor antagonist with anticancer activity 75
C24-hydroxylated stigmastane derivatives as Liver X Receptor agonists 74
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy 73
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience 72
Tumor-derived factors affecting immune cells 71
Vaccination in human solid tumors: Recent progress in the clinical arena 70
T cells as antigen carriers for anti-tumor vaccination 65
Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis 64
Chronic atrophic gastritis (GAC) and Helicobacter pylori infection eradication: a 3 years follow-up 64
Prognostic role of liver X receptor-alpha in resected stage II and III non-small-cell lung cancer 64
Preliminary evidences for recruitment of innate responses to rectal cancer cell death elicited by neo-adjuvant radio-chemo therapy 62
A clinical study of a cell-based MAGE-A3 active immunotherapy in advanced melanoma patients 61
Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors 60
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor promoting neutrophils. 59
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy 58
Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists 57
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 56
In search for novel liver X receptors modulators by extending the structure–activity relationships of cholenamide derivatives 55
il Melanoma 54
Modificazioni anatomiche e funzionali nella retinopatia solare 53
MAGE, BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas 52
Prognostic significance of cancer-testis gene expression in resected non-small cell lung cancer patients. 52
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice 52
Update on vaccines for melanoma patients 51
Expression of MAGE gene family in primary and metastatic human breast cancer. Implications for tumor antigen-specific immunotherapy 50
Identification of novel sense and antisense transcription at the TRPM2 locus in cancer 49
Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo 48
New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient 48
Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses 47
Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity 46
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes 46
Identification of a Promiscuous T-Cell Epitope Encoded by Multiple Members of the MAGE Family 44
The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells 43
The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells, and edits the cross-presentation of self, viral, and tumor antigens 43
Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response 43
The Hidden (And Lazy) TCR 43
The in vivo targeting of tumor antigens to DCs by administration of transduced autologous lymphocytes results in robust and prolonged immunization: Preclinical validation and results of a pilot clinical studies of vaccination for metastatic melanoma. 43
High homogeneity of MAGE, BAGE, GAGE, tyrosinase and melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: implications for protocol design of therapeutic antigen-specific vaccination strategies 43
Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients 42
Control of the immune system by oxysterols and cancer development 41
IRF1 and NF-kB Restore MHC Class I-Restricted Tumor Antigen Processing and Presentation to Cytotoxic T Cells in Aggressive Neuroblastoma 41
Enzymatic inactivation of oxysterols in breast tumor cells constraints metastasis formation by reprogramming the metastatic lung microenvironment 41
hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC 39
Targeting cholesterol homeostasis in hematopoietic malignancies 39
Fate mapping and scRNA sequencing reveal origin and diversity of lymph node stromal precursors 38
IL-7 AND IL-15 ALLOW THE GENERATION OF SUICIDE GENE-MODIFIED ALLOREACTIVE SELF-RENEWING CENTRAL MEMORY HUMAN T LYMPHOCYTES. 38
Functional Heterogeneity of HLA-A*02 Subtypes Revealed by Presentation of a MAGE-3-Encoded Peptide to Cytotoxic T Cell Clones. 37
LXR-dependent and -independent effects of oxysterols on immunity and tumor growth 36
Peptide-based vaccines for cancer therapy 36
Oxysterols act as promiscuous ligands of class-A GPCRs: In silico molecular modeling and in vitro validation 34
Molecular dissection of the migrating posterior lateral line primordium during early development in zebrafish 34
Therapeutic Regeneration of Lymphatic and Immune Cell Functions upon Lympho-organoid Transplantation 34
Metabolism, LXR/LXR ligands, and tumor immune escape 32
Enhancing the Efficacy of Melanoma Treatment: The In Vitro Chemosensitising Impact of Vipera ammodytes Venom on Human Melanoma Cell Lines 31
Comprehensive Genomic Characterization of Cutaneous Malignant Melanoma Cell Lines Derived from Metastatic Lesions by Whole-Exome Sequencing and SNP Array Profiling 31
Functional Heterodimerization between the G Protein-Coupled Receptor GPR17 and the Chemokine Receptors 2 and 4: New Evidence 28
Primary melanoma of the gastrointestinal tract 4
Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome 3
Totale 5.230
Categoria #
all - tutte 24.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202224 0 0 0 12 3 0 1 3 2 2 0 1
2022/2023165 75 34 13 0 0 17 6 11 4 0 0 5
2023/2024117 7 10 15 12 8 13 8 7 5 3 6 23
2024/2025781 73 9 2 11 21 33 64 53 119 218 70 108
2025/20264.132 300 425 380 613 330 129 259 304 995 156 140 101
Totale 5.230